Exit this survey
The AMA recently met with the Drug Enforcement Administration (DEA) to discuss the electronic prescription of controlled substances (EPCS). The DEA is seeking feedback from stakeholders on the barriers preventing or hindering prescribers from using health IT to perform EPCS. Please answer the questions below so feedback can be compiled and forwarded to DEA to provide a wider perspective of participation issues.

Question Title

What are the major disincentives for physicians who wish to participate in EPCS?

Question Title

What changes could be made to the current program requirements to increase EPCS uptake?

Question Title

Are there any other practical, functional, or cost issues that should be considered regarding EPCS?

( Privacy & Cookie Notice

T